In its first foray into Europe, Aralez Pharmaceuticals has opened up a Dublin office, with a view to hiring highly skilled workers by the end of the year.
Aralez Pharmaceuticals, which focuses on cardiovascular pain and other specialty areas, has left North America for the first time to set up an Irish office. The opening of a Dublin base will be a boon to the booming pharma sector in Ireland.
Aralez confirmed it would add “more highly skilled jobs in Dublin by the end of 2017”, but the number of jobs has yet to be revealed.
“The opening of our new Ireland headquarters is extremely important to Aralez,” said Adrian Adams, CEO of the company.
“Ireland has an excellent reputation as a leading location for talented professionals in the pharmaceutical industry, and will be essential to help us grow our operations over the next few years.”
Pharma companies have been very active in Ireland already in 2017. For example, 50 new jobs are to be created by Aerie Pharmaceuticals, which has entered into a lease agreement with the IDA to establish a new manufacturing plant in Athlone.
The 2,650 sq m facility will house the new plant, which is expected to produce commercial supplies for Aerie’s current product candidates, Rhopressa and Roclatan.
Meanwhile, Northern Irish pharma group Almac has announced plans to build a new facility in Dundalk, Co Louth, resulting in the creation of 100 jobs in the first two years.
Founded in 1968, the Almac Group has risen to become one of the country’s largest companies, and was the first business founded there to reach £1bn in value in 1997.
With a number of operations around the globe, including in the US, Japan and Singapore, the company has acquired its first site just across the border of Northern Ireland.
Looking for jobs in tech or science? Check out our Employer Profiles for information on companies hiring right now and sign up for our Career Republic e-zine for a weekly digest of sci-tech careers news and advice.
